Assignee
NAVITOR PHARM INC
US·18 granted patents·4 pending applications·78 citations·filing 2016–2025
Top patents by PatentIndex Score
22 records- 0197US11679090B2Modulators of Sestrin-GATOR2 interaction and uses thereofNAVITOR PHARM INC·Filed 2020·Granted Jun 20, 2023·4 cites·17 claims
- 0297US11325924B2Modulators of Sestrin-GATOR2 interaction and uses thereofNAVITOR PHARM INC·Filed 2020·Granted May 10, 2022·6 cites·6 claims
- 0396US10912750B2Modulators of Sestrin-GATOR2 interaction and uses thereofNAVITOR PHARM INC·Filed 2018·Granted Feb 9, 2021·10 cites·6 claims
- 0496US10752644B2Modulators of Sestrin-GATOR2 interaction and uses thereofNAVITOR PHARM INC·Filed 2019·Granted Aug 25, 2020·10 cites·3 claims
- 0593US10683308B2Rapamycin analogs and uses thereofNAVITOR PHARM INC·Filed 2016·Granted Jun 16, 2020·9 cites·14 claims
- 0693US10414782B2Modulators of sestrin-GATOR2 interaction and uses thereofNAVITOR PHARM INC·Filed 2018·Granted Sep 17, 2019·10 cites·3 claims
- 0792US10100066B2Modulators of sestrin-GATOR2 interaction and uses thereofNAVITOR PHARM INC·Filed 2016·Granted Oct 16, 2018·12 cites·4 claims
- 0888US11723890B2Methods of treatment using an mTORC1 modulatorNAVITOR PHARM INC·Filed 2020·Granted Aug 15, 2023·4 cites·18 claims
- 0988US11697633B2Polymorphic compounds and uses thereofNAVITOR PHARM INC·Filed 2022·Granted Jul 11, 2023·4 cites·20 claims
- 1087US10980784B2Rapamycin analogs and uses thereofNAVITOR PHARM INC·Filed 2019·Granted Apr 20, 2021·4 cites·4 claims
- 1186US12427130B2Modulators of Sestrin-GATOR2 interaction and uses thereofNAVITOR PHARM INC·Filed 2023·Granted Sep 30, 2025·0 cites·20 claims
- 1286US11345654B2Polymorphic compounds and uses thereofNAVITOR PHARM INC·Filed 2019·Granted May 31, 2022·4 cites·17 claims
- 1386US2026034084A1Modulators of sestrin-gator2 interaction and uses thereofNAVITOR PHARM INC·Filed 2025·Application pending·0 cites
- 1485US2026055122A1Modulators of sestrin-gator2 interaction and uses thereofNAVITOR PHARM INC·Filed 2025·Application pending·0 cites
- 1580US12378263B2Modulators of sestrin-GATOR2 interaction and uses thereofNAVITOR PHARM INC·Filed 2022·Granted Aug 5, 2025·0 cites·9 claims
- 1677US12252456B2Polymorphic compounds and uses thereofNAVITOR PHARM INC·Filed 2023·Granted Mar 18, 2025·0 cites·20 claims
- 1776US10414727B2Phenyl amino piperidine mTORC inhibitors and uses thereofNAVITOR PHARM INC·Filed 2017·Granted Sep 17, 2019·1 cites·17 claims
- 1872US12465583B2Methods of treatment using an mTORC1 modulatorNAVITOR PHARM INC·Filed 2023·Granted Nov 11, 2025·0 cites·21 claims
- 1966US2025188017A1Polymorphic compounds and uses thereofNAVITOR PHARM INC·Filed 2025·Application pending·0 cites
- 2062US10844013B2Phenyl amino piperidine mTORC inhibitors and uses thereofNAVITOR PHARM INC·Filed 2019·Granted Nov 24, 2020·0 cites·18 claims
- 2139US2019389843A1PYRROLE mTORC INHIBITORS AND USES THEREOFNAVITOR PHARM INC·Filed 2017·Application pending·0 cites
- 2237US11339144B2Heteroaryl Rheb inhibitors and uses thereofNAVITOR PHARM INC·Filed 2018·Granted May 24, 2022·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when NAVITOR PHARM INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →